Global Genetically Engineered Animal Models & Services Market Size is valued at USD 1.4 Bn in 2024 and is predicted to reach USD 3.8 Bn by the year 2034 at a 10.3% CAGR during the forecast period for 2025-2034.
Genetically Engineered Animal Models & Services entail the breeding of animals, primarily mice or rats, with altered genes to investigate human diseases, evaluate pharmaceuticals, and comprehend gene functions. Services encompass model construction, colony maintenance, genotyping, and preclinical testing. These models are crucial for pharmacological discovery, gene therapy assessment, and disease investigation. In biomedical research, these models are frequently employed to understand genetics and physiology better, investigate the underlying causes of diseases, and create and test possible remedies.
The growing need for cutting-edge research techniques and the rising incidence of chronic illnesses are the main factors propelling the market for genetically engineered animal models and services. Non-communicable diseases account for 71% of deaths worldwide, according to the World Health Organization (WHO), which has led to a surge in research efforts to determine the genetic foundation of these illnesses. Furthermore, researchers are being pushed to use genetically engineered animals in order to more accurately evaluate the safety and efficacy of drugs due to the pharmaceutical industry's demand for rapid drug development processes. These models allow scientists to more closely simulate human illnesses, which facilitates the creation of tailored treatments and personalized medicine solutions.
However, regulatory barriers can prolong and complicate research timeframes by slowing down the development and approval processes for genetically modified animals. Companies aiming to enter or grow within this sector may encounter obstacles because of the strict rules enforced by agencies such as the U.S. Food and Drug Administration (FDA). Whereas partnerships between commercial biotech companies and university institutions might help create novel models that propel market expansion. According to the National Science Foundation (NSF), the increase in financing for biotechnology research also indicates a favorable climate for developments in genetically engineered animal models & services.
Some Major Key Players In The Genetically Engineered Animal Models & Services Market:
The Genetically Engineered Animal Models & Services market is segmented based on Type of Services, Application, and End-user. The market is segmented by type of services into Custom Model Development, Consultation Services, Model Validation, Breeding Services, and Maintenance Services. By application, it includes Oncology, Immunology, Metabolic Disorders, Cardiovascular Diseases, and Neurological Disorders. Based on end-user, the market comprises Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Government Organizations.
The oncology category is expected to hold a major global market share in 2024, fueled by the growing need for better predictive preclinical models and the rising death rate from cancer. Oncology researchers frequently use genetically engineered animal models & services, especially mouse models, to mimic the pathophysiology of human cancer. This allows them to examine tumor growth, metastasis, and response to treatment in a controlled setting. Advanced animal models that can replicate particular genetic abnormalities seen in human tumors are becoming increasingly necessary due to the rise in targeted therapy development, immuno-oncology medications, and personalized medicine.
The market for genetically engineered animal models and services is expanding significantly in the Biotechnology Companies sector due to the growing complexity of drug development pipelines and the growing need for sophisticated preclinical research models. These businesses are using genetically engineered animal models & services to evaluate drug efficacy and safety before clinical trials, discover new therapeutic targets, and get a deeper understanding of disease causes. The quick uptake of CRISPR and other gene-editing technologies has further enabled biotechnology companies to produce accurate, personalized animal models, spurring innovation efficiently.
The North American Genetically Engineered Animal Models & Services market is expected to register the highest market share in revenue in the near future. The enormous investments in research and development, established research infrastructure, and the presence of numerous pharmaceutical and biotechnology companies are the reasons for the region's leadership. North America's market is growing mostly due to the United States, as the National Institutes of Health (NIH) is the world's largest supporter of biomedical research.
In addition, Asia Pacific is projected to grow rapidly in the global Genetically Engineered Animal Models & Services market. The need for genetically engineered animal models & services is being driven by the significant investments made in biotechnology and life sciences research by nations like China, Japan, and India.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1.4 Bn |
|
Revenue Forecast In 2034 |
USD 3.8 Bn |
|
Growth Rate CAGR |
CAGR of 10.3% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ BN and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type of Services, Application, and End-user |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Charles River Laboratories, Envigo, GenOway, Celerion, Crown Bioscience, Horizon Discovery, Crown Bioscience, Jackson Laboratory, Taconic Biosciences, In Vivo Therapeutics, BioIVT, and Celerion. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Genetically Engineered Animal Models Services Market Snapshot
Chapter 4. Global Genetically Engineered Animal Models Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Genetically Engineered Animal Models Services Market Industry Trends
4.10. Global Genetically Engineered Animal Models Services Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Genetically Engineered Animal Models Services Market Segmentation 1: By Application, Estimates & Trend Analysis
5.1. Market Share by Application, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
5.2.1. Oncology
5.2.2. Immunology
5.2.3. Metabolic Disorders
5.2.4. Cardiovascular Diseases
5.2.5. Neurological Disorders
Chapter 6. Genetically Engineered Animal Models Services Market Segmentation 2: By Type of Services, Estimates & Trend Analysis
6.1. Market Share by Type of Services, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Services:
6.2.1. Custom Model Development
6.2.2. Consultation Services
6.2.3. Model Validation
6.2.4. Breeding Services
6.2.5. Maintenance Services
Chapter 7. Genetically Engineered Animal Models Services Market Segmentation 3: By End-User, Estimates & Trend Analysis
7.1. Market Share by End-User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
7.2.1. Biotechnology Companies
7.2.2. Pharmaceutical Companies
7.2.3. Contract Research Organizations
7.2.4. Academic and Research Institutes
7.2.5. Government Organizations
Chapter 8. Genetically Engineered Animal Models Services Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Genetically Engineered Animal Models Services Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.3. North America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Type of Services, 2021-2034
8.2.4. North America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.3. Europe
8.3.1. Europe Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.3. Europe Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Type of Services, 2021-2034
8.3.4. Europe Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.3. Asia Pacific Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Type of Services, 2021-2034
8.4.4. Asia Pacific Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.5. Latin America
8.5.1. Latin America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.3. Latin America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Type of Services, 2021-2034
8.5.4. Latin America Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.3. Middle East & Africa Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by Type of Services, 2021-2034
8.6.4. Middle East & Africa Genetically Engineered Animal Models Services Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Charles River Laboratories
9.2.1.1. Business Overview
9.2.1.2. Key Application/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Envigo
9.2.3. GenOway
9.2.4. Celerion
9.2.5. Crown Bioscience
9.2.6. Horizon Discovery
9.2.7. Crown Bioscience
9.2.8. Jackson Laboratory
9.2.9. Taconic Biosciences
9.2.10. In Vivo Therapeutics
9.2.11. BioIVT
9.2.12. Celerion
9.2.13. Other Market Players
Segmentation of Genetically Engineered Animal Models & Services Market-
Genetically Engineered Animal Models & Services Market By Type of Services-
Genetically Engineered Animal Models & Services Market By Application-
Genetically Engineered Animal Models & Services Market By End-User-
Genetically Engineered Animal Models & Services Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
